novavax inc (NVAX:NASDAQ GS)
Earnings & Estimates Summary - NOVAVAX INC (NVAX)
2013 revenues at Novavax, Inc. totaled $20.9M USD, while annual losses equaled $0.31 per share.
Quarterly Earnings & Estimates - NOVAVAX INC (NVAX)
Novavax, Inc.'s Quarterly Earnings
Novavax, Inc. reported 2nd quarter 2014 losses of $0.08 per share on 08/8/2014.
Annual Earnings & Estimates - NOVAVAX INC (NVAX)
Novavax, Inc.'s Annual Earnings
Novavax, Inc. reported annual 2013 losses of $0.31 per share on 03/12/2014.
Quarterly Revenues - NOVAVAX INC (NVAX)
Novavax, Inc.'s Quarterly Revenues
Novavax, Inc. had 2nd quarter 2014 revenues of $8.3M USD. This missed the $10.6M USD consensus estimate of the 3 analysts following the company. This was 133.9% above the prior year's 2nd quarter results.
Annual Revenues - NOVAVAX INC (NVAX)
Novavax, Inc.'s Annual Revenues
Novavax, Inc. had revenues for the full year 2013 of $20.9M USD. This was -5.3% below the prior year's results.
|Celldex Therapeutics Inc||$25.54 USD||+0.60|
|Dynavax Technologies Corp||$17.60 USD||+0.10|
|Inovio Pharmaceuticals Inc||$7.08 USD||+0.045|
|Progenics Pharmaceuticals Inc||$6.51 USD||-0.12|
|ZIOPHARM Oncology Inc||$11.26 USD||-0.52|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|